News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EU Agency Backs Zeltia Group (18494051.MA) Drug for Ovarian Cancer


9/25/2009 6:52:19 AM

Bookmark and Share

Reuters -- Advisors to European regulators recommended Zeltia's Yondelis drug for use in the treatment of ovarian cancer, sending shares in the Spanish pharmaceutical firm sharply higher.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES